MDGL
Price
$212.04
Change
-$10.22 (-4.60%)
Updated
Apr 19, 6:59 PM EST
17 days until earnings call
VKTX
Price
$63.42
Change
-$1.25 (-1.93%)
Updated
Apr 19, 6:59 PM EST
4 days until earnings call
Ad is loading...

Analysis and predictions MDGL vs VKTX

Header iconMDGL vs VKTX Comparison
Open Charts MDGL vs VKTXBanner chart's image
Madrigal Pharmaceuticals
Price$212.04
Change-$10.22 (-4.60%)
Volume$299.02K
CapitalizationN/A
Viking Therapeutics
Price$63.42
Change-$1.25 (-1.93%)
Volume$1.79M
CapitalizationN/A
View a ticker or compare two or three
MDGL vs VKTX Comparison Chart

Loading...

MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VKTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MDGL vs. VKTX commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a Hold and VKTX is a Hold.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (MDGL: $212.04 vs. VKTX: $63.42)
Brand notoriety: MDGL and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 114% vs. VKTX: 41%
Market capitalization -- MDGL: $4.45B vs. VKTX: $6.98B
MDGL [@Biotechnology] is valued at $4.45B. VKTX’s [@Biotechnology] market capitalization is $6.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, VKTX is a better buy in the long-term than MDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 2 bullish TA indicator(s).

  • MDGL’s TA Score: 4 bullish, 6 bearish.
  • VKTX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both MDGL and VKTX are a bad buy in the short-term.

Price Growth

MDGL (@Biotechnology) experienced а -10.38% price change this week, while VKTX (@Biotechnology) price change was -7.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.06%. For the same industry, the average monthly price growth was -5.49%, and the average quarterly price growth was +1224.51%.

Reported Earning Dates

MDGL is expected to report earnings on Aug 06, 2024.

VKTX is expected to report earnings on Jul 24, 2024.

Industries' Descriptions

@Biotechnology (-7.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
A.I.dvisor published
a Summary for VKTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VKTX($6.99B) has a higher market cap than MDGL($4.45B). VKTX YTD gains are higher at: 240.785 vs. MDGL (-8.359).
MDGLVKTXMDGL / VKTX
Capitalization4.45B6.99B64%
EBITDAN/AN/A-
Gain YTD-8.359240.785-3%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MDGL vs VKTX: Fundamental Ratings
MDGL
VKTX
OUTLOOK RATING
1..100
5572
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
5414
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
5334
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a13

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDGL's Valuation (68) in the Pharmaceuticals Other industry is in the same range as VKTX (78) in the Biotechnology industry. This means that MDGL’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (14) in the Biotechnology industry is somewhat better than the same rating for MDGL (54) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew somewhat faster than MDGL’s over the last 12 months.

VKTX's SMR Rating (96) in the Biotechnology industry is in the same range as MDGL (99) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to MDGL’s over the last 12 months.

VKTX's Price Growth Rating (34) in the Biotechnology industry is in the same range as MDGL (53) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to MDGL’s over the last 12 months.

VKTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MDGL (100) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to MDGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDGLVKTX
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 24 days ago
78%
Bullish Trend 25 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
View a ticker or compare two or three
Ad is loading...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VKTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UMDD22.560.25
+1.13%
ProShares UltraPro MidCap400
DEW49.040.50
+1.02%
WisdomTree Global High Dividend ETF
NUMV32.210.14
+0.44%
Nuveen ESG Mid-Cap Value ETF
CRIT19.36-0.10
-0.51%
Optica Rare Earths & Critical Matrls ETF
SECT47.41-0.33
-0.69%
Main Sector Rotation ETF

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with IBRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-4.60%
IBRX - MDGL
62%
Loosely correlated
+7.33%
KA - MDGL
62%
Loosely correlated
+8.41%
VXRT - MDGL
61%
Loosely correlated
-10.29%
SRNEQ - MDGL
58%
Loosely correlated
N/A
RLAY - MDGL
57%
Loosely correlated
-2.45%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-1.93%
JANX - VKTX
66%
Loosely correlated
-0.33%
CTMX - VKTX
55%
Loosely correlated
-3.47%
DNLI - VKTX
47%
Loosely correlated
-3.61%
LGND - VKTX
47%
Loosely correlated
-0.07%
BEAM - VKTX
46%
Loosely correlated
-1.69%
More